Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

  • This share is currently suspended. It was suspended at a price of 7.23
  • There is currently no data for TRX

AGM Statement

28 Apr 2005 07:00

Torex Retail PLC28 April 2005 Torex Retail Plc AGM Statement Torex Retail Plc ("Torex Retail" or "the Group"), the UK's market leader inretail IT solutions, will today hold its inaugural Annual General Meeting. RobLoosemore, Chairman, will comment on current trading as follows: "Torex Retail performed strongly in 2004 and the momentum developed during lastyear has been carried forward into 2005. We are pleased to report that tradingto date is in line with our expectations and, with buoyant market conditions anda high level of revenue visibility, the Board remain confident of both our fullyear forecasts and the future growth prospects for the Group. In addition, we are delighted with the progress made by the Alphameric RetailDivision (ARD), which was acquired in November 2004, and which continues totrade in line with our expectations. This reflects new business wins (AnnTaylor and Littlewoods) for our Smartdecision merchandise planning product,coupled with decisive action taken to reduce the cost base. The division is nowfully integrated into the Torex Retail business." Other highlights include: • First installations of Lucas into the UK: Following the successful launch in the UK of Lucas, our market leading Java EPOS solution, installations have already been completed with Esprit, Deichmann shoe stores and a major regional department store. Further announcements are expected shortly. • Cross selling of Lucas is ahead of schedule. The very strong demand for Lucas from the former ARD customer base has resulted in a number of early contract wins, including JD Sports with installations into their 68 UK stores planned for the next quarter. In addition, Lucas has already been installed in Reiss' flagship New York store and Nora O'Connell stores in Ireland. Chris Moore, Chief Executive, comments: "I am delighted with the start we have made to the year. Most encouraging hasbeen the new contract wins for Lucas, in particular, the deal with JD Sports inthe face of stiff competition. This win, together with the UK Lucas sales, willprovide valuable reference sites from which to leverage Lucas further into theUK market. The outlook for the full year remains very positive." It is expected that the Group's interim results for the six months ending 30June, 2005 will be announced in mid September 2005. Enquiries: Torex Retail 0870 050 9900 Rob Loosemoore, Chairman / Richard Thompson, FD Citigate Dewe Rogerson 020 7638 9571 Ginny Pulbrook / Sebastian Hoyle / Lucie Holloway This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th Mar 20157:09 amRNSDermaPure gains Medicare coverage approval
5th Mar 20151:36 pmRNSIssue of equity and total voting rights
5th Mar 20151:18 pmRNSIssue of equity and total voting rights
5th Mar 201510:38 amRNSUK Patient has world's first OrthoPure XM implant
26th Feb 201510:43 amRNSResignation of Dr Alison Fielding
9th Feb 201512:05 pmRNSResult of General Meeting
4th Feb 201510:59 amRNSIssue of equity and total voting rights
22nd Jan 201511:13 amRNSResults of Placing
22nd Jan 20157:00 amRNSProposed placing of new Ordinary Shares
1st Dec 20149:45 amRNSHolding(s) in Company
28th Nov 20149:45 amRNSHolding(s) in Company
25th Nov 20148:15 amRNSNotice of allowance for US meniscus patent
5th Nov 20147:00 amRNSTissue Regenix gains Medicare and Medicaid Q code
29th Oct 20147:00 amRNSInterim Results
22nd Oct 20149:01 amRNSInterim Results and Capital Markets Day
20th Oct 201410:19 amRNSdCELL(R) presented at prestigious EACTS congress
17th Oct 20143:35 pmRNSInitial Clinical Trial Results
10th Sep 20149:00 amRNSdCELL® technology presented at Royal Society event
30th Jul 20147:00 amRNSUK meniscus clinical trial & DermaPure US updates
25th Jul 20147:00 amRNSTissue Regenix adds European bladder matrix patent
18th Jul 201411:11 amRNSIssue of equity and total voting rights
27th Jun 20143:06 pmRNSResult of AGM
12th Jun 20147:00 amRNSTissue Regenix announces launch of DermaPure in US
22nd May 20147:00 amRNSPreliminary Decision to Approve "Q" Code Request
20th May 20147:00 amRNSDeferred Annual Bonus Award
19th May 201410:21 amRNSAnnual Report & Accounts and Notice of AGM
19th May 20147:00 amRNSPreliminary results for year ended 31 January 2014
16th May 20141:00 pmRNSTissue Regenix adds US patent
12th May 201411:00 amRNSNotice of Preliminary Results
30th Apr 20145:14 pmRNSHolding(s) in Company
28th Apr 20147:00 amRNSTissue Regenix adds Chinese patent
24th Apr 20148:40 amRNSHolding(s) in Company
4th Feb 20143:03 pmRNSIssue of Share Options
31st Jan 20141:11 pmRNSHolding(s) in Company
14th Jan 20145:22 pmRNSIssue of equity and total voting rights
9th Jan 201411:11 amRNSIssue of equity and total voting rights
19th Dec 20137:00 amRNSTissue Regenix to attend JPMorgan Healthcare Event
12th Dec 20137:00 amRNSTissue Regenix signs US distribution agreements
22nd Nov 20137:00 amRNSDirector Share Purchase
29th Oct 20137:00 amRNSPresentation at Proactiveinvestors Forum in Dublin
28th Oct 20134:49 pmRNSDirector Share Purchase
21st Oct 20137:00 amRNSPublication of DermaPure UK trial results
17th Oct 20134:41 pmRNSHolding(s) in Company
17th Oct 20134:41 pmRNSHolding(s) in Company
17th Oct 20134:41 pmRNSHolding(s) in Company
14th Oct 20137:00 amRNSTissue Regenix USA successful technology transfer
8th Oct 20137:00 amRNSInterim Results for six months ended 31 July 2013
12th Aug 20137:00 amRNSTissue Regenix USA Appoints VP of Marketing
6th Aug 20139:41 amRNSHolding(s) in Company
5th Aug 20137:00 amRNSTissue Regenix USA Appoints VP of Operations

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.